Health
Alzheimer's drug safe and effective
NEWS IN BRIEF — Posted Jan. 30, 2006
Memantine, a drug approved for the treatment of Alzheimer's disease, appears safe and effective in patients with moderate to severe cases of the condition, according to a study in the January Archives of Neurology.
For an open-label extension trial, 175 patients with moderate to severe Alzheimer's who had completed an earlier double-blind study of memantine received 20 mg of the drug daily for 24 weeks.
Cognitive tests, reports from caregivers and observations by clinicians all indicated that memantine was beneficial to the patients.
The data "provide additional assurance to prescribing physicians that long-term use of memantine is safe, continues to have a low rate of adverse effects and may have continuing beneficial clinical effects," wrote Jeffrey L. Cummings, MD, director of the Alzheimer's Disease Research Center at the University of California, Los Angeles, in an accompanying editorial.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/01/30/hlbf0130.htm.












